Its really exceptional discovery from Indrani, it seems the study still in very very preliminary stage. Its lacking invivo experimental results, which are very crucial for further consideration of this novel path of HIV elimination in order to consider for preclinical studies. The selection rate for preclinical studies as follows: an example (to my knowledge only)
Laboratory discoveries : 100 In vivo sucess : less than 50% Preclinical studis PHase I Phase II Phase II : only one 1% of above discoveries will qualify.
I wish Indrani all the best to make it to FURTHER crucial steps.
